8 6 5 a r t I C l e S Growth, guidance and terminal arborization of axons are regulated by many extracellular signals that either promote or inhibit axon extension and influence axon trajectory by acting as either attractants or repellents at the growth cone 1 . The sympathetic neurons of the mouse superior cervical ganglion (SCG) comprise an extensively studied, experimentally tractable population of neurons for investigating regulation of axonal growth and innervation of the target field in the developing peripheral nervous system 2,3 . Secreted proteins that promote growth of sympathetic axons at different stages of development include nerve growth factor (NGF), neurotrophin 3, glial cell-derived neurotrophic factor, artemin and hepatocyte growth factor. Of these, the most extensively studied and best understood is NGF, which is produced in target tissues and promotes the growth and branching of sympathetic axons in many of these tissues 4 . Target-derived NGF is also required for and regulates the survival of developing sympathetic neurons 2,3 .
Growth, guidance and terminal arborization of axons are regulated by many extracellular signals that either promote or inhibit axon extension and influence axon trajectory by acting as either attractants or repellents at the growth cone 1 . The sympathetic neurons of the mouse superior cervical ganglion (SCG) comprise an extensively studied, experimentally tractable population of neurons for investigating regulation of axonal growth and innervation of the target field in the developing peripheral nervous system 2, 3 . Secreted proteins that promote growth of sympathetic axons at different stages of development include nerve growth factor (NGF), neurotrophin 3, glial cell-derived neurotrophic factor, artemin and hepatocyte growth factor. Of these, the most extensively studied and best understood is NGF, which is produced in target tissues and promotes the growth and branching of sympathetic axons in many of these tissues 4 . Target-derived NGF is also required for and regulates the survival of developing sympathetic neurons 2, 3 .
Recent work has shown that several members of the TNF superfamily can modulate neurite growth in the developing nervous system. For example, in certain populations of neurons, FasL and GITRL enhance neurite growth [5] [6] [7] , whereas TNFα, LIGHT and RANKL decrease neurite growth [8] [9] [10] [11] . TNF superfamily members are type II transmembrane glycoproteins that are active both as membrane-integrated ligands and as soluble ligands after cleavage from the cell membrane and exert their effects by binding to members of the TNFR superfamily 12 . In addition to functioning as ligands, several membrane-integrated TNF superfamily members act as reverse signaling receptors for their respective TNFR superfamily partners in cell lines and several cell types of the immune system 13 . Here we report the occurrence of TNF superfamily reverse signaling in the nervous system. We demonstrate that TNFR1 acts as a ligand for membrane-integrated TNFα expressed along the axons of postnatal SCG neurons and that TNFR1-activated TNFα reverse signaling promotes axon growth and tissue innervation by a mechanism dependent on ERK1 and ERK2.
RESULTS

TNFa and its receptors in SCG neurons and targets
To clarify the role of TNFα in development of sympathetic neurons, we analyzed expression of TNFα and its receptors, TNFR1 and TNFR2, in SCG neurons and tissues innervated by these neurons. In low-density dissociated cultures of SCG neurons from a postnatal day 0 (P0) mice, we observed intense TNFα immunoreactivity in the cell bodies and throughout the neurite arbors of the neurons. In marked contrast, intense TNFR1 immunoreactivity was restricted to the neuron cell bodies, and the neurites were completely unlabeled ( Fig. 1a) . Accordingly, in histological sections of the SCG, neuron cell bodies were labeled by both anti-TNFα and anti-TNFR1, and post-ganglionic sympathetic fiber bundles, identified by tyrosine hydroxylase immunostaining, were labeled by anti-TNFα but not by anti-TNFR1 ( Fig. 1b) . We observed weak TNFR2 immunoreactivity in cell bodies and neurites of the neurons (data not shown). Quantification of Tnf and Tnfrsf1a transcripts in dissected SCG revealed a gradual increase in the amounts of these mRNAs from embryonic day 13 (E13) to reach a peak in expression by postnatal day 5 (P5), followed by a decline to low or negligible levels in the adult (Fig. 1c,d) .
In the SCG target tissues analyzed in this study (submandibular salivary gland, nasal turbinate tissue and iris), tyrosine hydoxylasepositive sympathetic fibers were clearly labeled by anti-TNFα, but were not labeled by anti-TNFR1 ( Fig. 1e) . Submandibular gland tubules exhibited clear TNFR1 immunostaining and a low level of TNFα immunostaining. Connective tissue in the core of nasal turbinates, where blood vessels and sympathetic fibers are concentrated, was immunostained by anti-TNFR1, whereas the mucosa was labeled by anti-TNFα. The connective tissue of the iris was labeled by both anti-TNFα and anti-TNFR1 ( Fig. 1e) . Sections incubated with secondary antibody alone exhibited no background immunofluorescence, and tissue sections obtained a r t I C l e S from Tnf −/− and Tnfrsf1a −/− mice were not labeled by anti-TNFα and anti-TNFR1, respectively (data not shown).
TNFa reverse signaling promotes sympathetic axon growth Our finding that TNFα is expressed on postnatal sympathetic axons ramifying in TNFR1-expressing targets raised the possibility that targetderived TNFR1 might act as a reverse-signaling ligand for TNFα. To examine the possibility that TNFα reverse signaling might influence growth of sympathetic axons, we cultured P0 SCG neurons with NGF to sustain their survival with and without a divalent TNFR1-Fc chimera (in which the extracellular domains of two TNFR1 molecules are linked to the Fc part of a human IgG1 antibody) that has been shown to be a potent reverse-signaling ligand for TNFα 14 . After a 24-h incubation, the neurite arbors of neurons treated with the TNFR1-Fc were larger than those grown with NGF alone ( Fig. 2a,b) . Quantification of the size and complexity of the neurite arbors revealed that the TNFR1-Fc chimera had highly significantly greater neurite length and number of branch points ( Fig. 2c,d ; statistical details in figure legends), and the Sholl profiles, which plot neurite branching with distance from the cell body, were larger in the presence of TNFR1-Fc ( Fig. 2e) . NGFsupplemented neurons treated with an Fc protein fragment did not have significantly larger neurite arbors than neurons grown with NGF alone ( Fig. 2c-e ), indicating that the Fc fragment of the TNFR1-Fc chimera did not affect neurite growth. Dose-response analysis (data not shown) revealed that the effect of the TNFR1-Fc chimera on neurite growth reached a plateau at 10 ng ml −1 . Soluble recombinant monovalent TNFR1 (sTNFR1), which activites TNFα reverse signaling at much higher concentrations [15] [16] [17] , also significantly enhanced neurite growth and branching ( Fig. 2c-e ). Cell counts showed that neither the TNFR1-Fc chimera nor sTNFR1 significantly affected neuron survival in these NGF-supplemented cultures (neurons surviving 24 h after plating expressed as a percentage of the number plated (mean ± s.e.m.): NGF alone, 79.4% ± 8.4%; NGF with TNFR1-Fc, 83.9% ± 7.8% (P = 0.674 versus NGF alone); NGF with sTNFR1, 97.2% ± 9.4% (P = 0.142 versus NGF alone); n = 3 experiments, t-test).
To verify that TNFα is essential for enhancement of neurite growth by TNFR1-Fc, we compared the effects of TNFR1-Fc on cultures of SCG neurons obtained from Tnf +/+ , Tnf +/− and Tnf −/− mice. For these studies, we crossed Tnf +/− mice and established separate SCG neuron cultures from each littermate. The Sholl profiles of SCG neurons of newborn Tnf +/+ and Tnf +/− mice grown with TNFR1-Fc plus NGF were markedly larger than those grown with NGF alone, whereas the Sholl profiles of SCG neurons of newborn Tnf −/− mice grown with NGF and TNFR1-Fc and without TNFR1-Fc were very similar ( Fig. 2f) . Whereas TNFR1-Fc caused highly significant increases neurite length and branch point number in the neurite arbors of neurons cultured from newborn Tnf +/+ and Tnf +/− mice (P < 0.001, n = 150 neurons per condition from three separate experiments, Fisher's post hoc test; data not shown), TNFR1-Fc had no significant effect on neurite arbor size in cultures established from newborn Tnf −/− mice (P = 0.14 for length, P = 0.21 for branch number, n = 150 neurons per condition from three separate experiments, Fisher's post hoc test; data not shown). These results demonstrate that TNFα is essential for the effect of TNFR1-Fc on neurite growth. In contrast to TNFα-deficient neurons, TNFR1-deficient neurons responded, just as wild-type neurons did, to TNFR1-Fc and sTNFR1 with enhanced neurite growth ( Fig. 2g) .
To determine whether membrane-integrated TNFα is required for enhancement of neurite growth by TNFR1-Fc, we pretreated P0 SCG neurons with TNFα-converting enzyme TACE, also known as ADAM17, a metalloproteinase that cleavages and releases the ectodomain of membrane-integrated TNFα 18 , thereby preventing reverse signaling. Sholl analysis revealed that neurite arbors of neurons cultured with TACE plus TNFR1-Fc were smaller than those of neurons cultured with TNFR1-Fc alone ( Fig. 2h) . Culture with TACE resulted in significantly smaller neurite length and number of branch points relative to neurons treated with TNFR1-Fc (P < 0.01, 234 control neurons, 243 TNFR1-Fc-treated neurons, 247 TACE-treated neurons and 258 TACE plus TNFR1-Fc-treated neurons; Kruskal-Wallis test, data not shown). These findings are consistent with transduction of the TNFR1-Fc signal by intact membrane-integrated TNFα.
To examine whether TNFR1 can enhance neurite growth independently of NGF, we cultured Bax-deficient neonatal SCG neurons, which do not undergo apoptosis in the absence of NGF 19 npg a r t I C l e S these neurons were much smaller than those of neurons grown with NGF, Sholl analysis revealed that TNFR1-Fc increased the size and complexity of neurite arbors ( Fig. 2i) . We carried out similar experiments using SCG neurons from wild-type neurons treated with the cell-permeant broad-spectrum caspase inhibitor Q-VD-OPh to prevent apoptosis in the absence of NGF. In these experiments, treatment with TNFR1-Fc likewise significantly increased the size and complexity neurite arbors (P < 0.001, n = 196 control neurons and 175 TNFR1-Fc-treated neurons, Fisher's post hoc test; data not shown).
To determine whether TNFR1-Fc enhances neurite growth during a particular phase of sympathetic neuron development, we examined the effect of TNFR1-Fc on SCG neuron cultures established over a range of ages. Sholl analysis revealed that TNFR1-Fc did not enhance neurite growth from either embryonic day 18 (E18) or P10 SCG neurons, but enhanced neurite arbor size and complexity from P0 and P5 neurons ( Fig. 3a) . This indicates that TNFα reverse signaling enhances neurite growth from SCG neurons during a restricted period of postnatal development when the axons of these neurons are ramifying in their target tissues.
TNFR1-Fc acts locally on axons to enhance their growth
Expression of TNFR1 in sympathetic target tissues raises the possibility that it acts as a reverse-signaling ligand on the TNFα-expressing sympathetic axon terminals to promote their growth locally as they ramify in these tissues. To test whether TNFR1 can act locally on sympathetic axon terminals to promote growth, we cultured sympathetic neurons in microfluidic devices in which the cell soma and growing axon terminals are cultured in different compartments separated by a barrier (Fig. 3b) . We seeded P0 SCG neurons into one compartment (the soma compartment) of a two-compartment device that contained NGF in both compartments to sustain neuronal survival and encourage axon growth from the soma compartment into the axon compartment. We added TNFR1-Fc to either the soma or axon compartment and used an Fc protein fragment as control. After a 24-h incubation, we labeled the axons in the axon compartment with the fluorescent vital dye calcein-AM, which also retrogradely labels cell bodies of neurons that project axons into the axon compartment. We used a stereological method to quantify the extent of axon growth in the axon compartment relative to the number of neurons projecting axons into this compartment. Addition of TNFR1-Fc to the axon compartment resulted in a marked and highly significant increase in axon growth in this compartment compared to Fc-treated controls npg a r t I C l e S (P < 0.001, n = 9 experiments, Fisher's post hoc test). In contrast, addition of TNFR1-Fc to the soma compartment had no significant effect on axon growth in the axon compartment ( Fig. 3c,d) . These results suggest that TNFR1 expressed in sympathetic targets can act locally to enhance the growth of sympathetic axon terminals ramifying in these tissues.
We have previously shown that soluble TNFα markedly lowers the extent of NGF-promoted neurite growth from cultured neonatal SCG neurons 9 . Additional compartment culture experiments showed that TNFα only impaired axon growth if we added it to the soma compartment, not the axon compartment ( Fig. 3e) . Our demonstration that the inhibitory effect of soluble TNFα on neurite growth is completely eliminated by deletion of the gene encoding TNFR1, Tnfrsf1a (Fig. 3f) , suggests that soluble TNFα exerts this effect via TNFR1. Our finding that inhibition of neurite growth is observed when TNFα is applied to the cell soma, not axon terminals, of the neurons is consistent with the restriction of TNFR1 expression to the cell soma ( Fig. 1) and suggests that TNFα expressed in target tissues in vivo has no role in regulating the density of sympathetic innervation.
Diminished innervation density in Tnf −/− and Tnfrsf1a −/− mice To ascertain whether the increase in sympathetic axon growth and branching brought about by TNFR1-activated TNFα reverse signaling in vitro is physiologically relevant for the establishment of sympathetic innervation in vivo, we used tyrosine hydroxylase immunofluorescence to identify sympathetic fibers and quantify sympathetic innervation density 20 in mice that are homozygous or heterozygous for targeted deletions of Tnf 21 and Tnfrsf1a 22 and in their wild-type littermates. We chose iris, nasal turbinate tissue and submandibular gland for this analysis because they receive a dense innervation of sympathetic fibers from the SCG. We initially carried out this analysis at P10, which is immediately after the period of development when TNFR1-activated TNFα reverse signaling enhances neurite growth in vitro and is at a stage in vivo when the sympathetic innervation of these tissues has become well established.
We crossed Tnf +/− mice to generate litters of Tnf +/+ , Tnf +/− and Tnf −/− pups and crossed Tnfrsf1a +/− mice to generate litters of Tnfrsf1a +/+ , Tnfrsf1a +/− and Tnfrsf1a −/− pups. Sections of the iris, nasal turbinate tissue and submandibular gland of Tnf −/− and Tnfrsf1a −/− mice had less tyrosine hydroxylase immunofluorescence compared those of with wild-type littermates ( Fig. 4) . Tyrosine hydroxylase immunofluorescence was significantly lower in these tissues in both Tnf −/− mice ( Fig. 4b-d ) and Tnfrsf1a −/− mice ( Fig. 4f-h) compared to wild-type littermates. Tyrosine hydroxylase immunofluorescence was also lower in the tissues of Tnf +/− and Tnfrsf1a +/− mice compared with wild-type mice, although these decreases were only significant in the nasal turbinate tissue of Tnf +/− mice ( Fig. 4c ) and the submandibular gland of Tnfrsf1a +/− mice (Fig. 4h) .
To exclude the possibility that the decreases in tyrosine hydroxylase immunofluorescence in the tissues of Tnf −/− and Tnfrsf1a −/− mice were secondary to downregulation of tyrosine hydroxylase expression in the innervating neurons, we used western blotting to quantify the amounts of tyrosine hydroxylase protein in the SCG of these mice and the corresponding wild-type mice. This analysis revealed no significant differences in the levels of tyrosine hydroxylase protein relative to the level of the neuron-specific β-III tubulin protein in the SCG of Tnf −/− mice and Tnfrsf1a −/− mice ( Supplementary Fig. 1 ) compared with the ganglia of wild-type mice npg a r t I C l e S at P10 (P = 0.914 for Tnf −/− versus Tnf +/+ and P = 0.697 for Tnfrsf1a −/− versus Tnfrsf1a +/+ ; n = 3 mice of each genotype, t-test).
To determine whether the diminished density of sympathetic innervation observed in the tissues of Tnf −/− and Tnfrsf1a −/− mice was secondary to the smaller size of the innervating population of neurons, we counted the neurons in the SCG of Tnf −/− and Tnfrsf1a −/− mice and in their wild-type littermates at P10. These counts revealed no significant differences in the numbers of SCG neurons between Tnf −/− and Tnf +/+ mice and between Tnfrsf1a −/− and Tnfrsf1a +/+ mice (Supplementary Fig. 1c,f ; P = 0.624 for Tnf −/− versus Tnf +/+ and P = 0.902 for Tnfrsf1a −/− versus Tnfrsf1a +/+ ; n = 3 mice of each genotype, t-test). Taken together, these results demonstrate that TNFα and TNFR1 have a crucial role in establishing sympathetic innervation in vivo and suggest that the influence of TNFR1-activated TNFα reverse signaling on axon growth and branching is physiologically relevant.
To ascertain whether the diminished density of sympathetic innervation observed in Tnf −/− and Tnfrsf1a −/− mice at P10 is maintained in the mature nervous system, we quantified tyrosine hydroxylase immunofluorescence in sections of the anatomically circumscribed tissues of the iris and submandibular salivary gland of adult mice. This analysis not only revealed highly significant decreases in tyrosine hydroxylase immunofluorescence in both tissues in Tnf −/− and Tnfrsf1a −/− adult mice compared to age-matched wild-type mice ( Fig. 5a-f ), but the proportion of decrease was greater than that observed at P10, especially in the submandibular gland, where tyrosine hydroxylase immunofluorescence was 70-80% lower in Tnf −/− and Tnfrsf1a −/− mice relative to the corresponding wild-type adult mice (Fig. 5c,f) . These findings suggest that TNFα and TNFR1 have an ongoing role in maintaining sympathetic innervation in vivo.
We also used tyrosine hydroxylase staining in whole-mount tissue preparations to visualize sympathetic innervation in TNFα-deficient and TNFR1-deficient mice. This technique was especially suitable for analyzing the soft tissue of the submandibular gland. There sympathetic nerves enter the gland at the hilus and subsequently split into many branches that ramify extensively in the gland. These preparations, carried out on tissue from P10 littermates, revealed very clear differences in branching of sympathetic fibers between Tnf −/− and Tnfrsf1a −/− mice and the corresponding wild-type littermates. Whereas tyrosine hydroxylase-immunopositive nerves branched into multiple finer branches near the hilus in wild-type mice, tyrosine hydroxylase-immunopositive nerves at the glandular hilus of Tnf −/− mice and Tnfrsf1a −/− mice did not give off as many branches, and the main nerve trunk had a tapped appearance, suggesting that whereas npg a r t I C l e S sympathetic nerves reach this gland, many fibers did not grow into and ramify in this tissue (Fig. 5g) . Using a stereological method to estimate the extent of branching near the hilus, we found highly significant decreases in the number of nerve branches in Tnf −/− mice (37.3% ± 7.0% decrease in nerve branches in Tnf −/− mice relative to Tnf +/+ mice (mean ± s.e.m.; P < 0.0001, n = 4 Tnf −/− mice and n = 3 Tnf +/+ mice, Fisher's post hoc test)) and Tnfrsf1a −/− mice (17.9% ± 5.1% decrease in nerve branches in Tnfrsf1a −/− mice relative to Tnfrsf1a +/+ mice (mean ± s.e.m., P < 0.003, n = 6 Tnfrsf1a −/− mice, n = 7 Tnfrsf1a +/+ mice, Fisher's post hoc test)).
To corroborate our conclusion based on tyrosine hydroxylase immunohistochemistry experiments that Tnf −/− and Tnfrsf1a −/− mice have lower density of sympathetic innervation compared with wild-type mice, we used dopamine β-hydroxylase (DBH) immunohistochemistry as another marker of sympathetic fibers in tissue sections of separate sets of P10 mutant and wild-type mice. Although this analysis was based on a smaller number of mice, DBH immunofluorescence was nonetheless highly significantly lower in the iris, nasal turbinate tissue and submandibular gland of both Tnf −/− mice compared to wild-type mice (P = 0.0014 for iris, P = 0.0146 for nasal turbinate tissue and P = 0.0014 for submandibular gland; n = 3 of each genotype, Fisher's post hoc test) and Tnfrsf1a −/− mice compared to wild-type mice (P = 0.00143 for iris, P = 0.00144 for nasal turbinate tissue and P = 0.00026 for submandibular gland, n = 3 of each genotype, Fisher's post hoc test; Supplementary Fig. 2) . Furthermore, we observed significant decreases in DBH immunofluorescence in the nasal turbinate tissue of Tnf +/and Tnfrsf1a +/mice relative to wild type mice (P = 0.024 and 0.0016, respectively, n = 3 of each genotype, Fisher's post hoc test).
TNFR1-Fc enhances axonal growth by activating ERK1 and ERK2
To study the molecular mechanism underlying the enhancement of neurite growth from SCG neurons by TNFα reverse signaling, we explored a common link in intracellular signaling between the control of neurite growth and TNFα reverse signaling in the immune system. ERK1 and ERK2 have been shown to be activated both by TNFα reverse signaling in monocytes 23 and by NGF in PC12 cells and in SCG neurons, and to contribute to growth of neurites in response to NGF 7,24-26 .
To investigate whether ERK signaling contributes to TNFR1promoted neurite growth from SCG neurons, we first tested whether TNFR1-Fc activates ERK1 and ERK2 in these neurons. In these experiments, we cultured P0 SCG neurons for 12 h with NGF before treating them with TNFR1-Fc. The initial period of culture permitted phospho-ERK1 and phospho-ERK2 to reach a basal level so that any subsequent increase could be observed more easily. Treatment with TNFR1-Fc after 12 h caused rapid increases in the amounts of phospho-ERK1 and phospho-ERK2 within 5 min, which returned to basal levels within 30-45 min (Fig. 6a) .
To determine whether treatment with TNFR1-Fc can result in activation of ERK1 and ERK2 independently of NGF, we initially cultured P0 SCG neurons for 12 h with the caspase inhibitor Q-VD-OPh to prevent apoptosis in the absence of NGF before treatment with TNFR1-Fc. As with neurons maintained with NGF, treatment with TNFR-Fc caused a rapid transient increase in the amounts phospho-ERK1 and phospho-ERK2 (Fig. 6b) . Likewise, Bax-deficient SCG neurons cultured in the absence of NGF exhibited very similar changes in the amounts of phospho-ERK1 and phospho-ERK2 after treatment with TNFR1-Fc after 12 h of culture (Fig. 6c) . To confirm that TNFα is needed for the activation of ERK1 and ERK2 by TNFR1-Fc, we treated SCG neurons obtained from Tnf −/− mice with TNFR1-Fc. We observed no significant changes in phospho-ERK1 and phospho-ERK2 relative to total ERK1 and total ERK2 protein in TNFα-deficient neurons after treatment with TNFR1-Fc (Fig. 6d) . Taken together, these results show that TNFα reverse signaling causes rapid, transient activation of ERK1 and ERK2 independently of NGF.
To investigate whether ERK1 and ERK2 activation is responsible for the enhanced neurite growth brought about by TNFR1-Fc, a r t I C l e S we examined whether U0126, a selective MEK1 and MEK2 inhibitor that interferes with MEK1 and MEK2-dependent activation of ERK1 and ERK2 (ref. 27) , could prevent the increase in neurite growth. In these experiments, we plated P0 SCG neurons in NGF-free medium containing Q-VD-OPh and pretreated these neurons for 2 h with either U0126 or the inactive analog U0124 before adding TNFR1-Fc and imaging and quantifying the neurite arbors 24 h later. U0126, but not U0124, completely prevented TNFR1-Fc-enhanced neurite growth, as shown by quantification of branch point number (Fig. 6e ) and neurite length (Fig. 6f) . This suggests that MEK and ERK signaling has a crucial role in mediating the effect of TNFα reverse signaling on neurite growth. Previous studies in a macrophage cell line have shown that activation of TNFα reverse signaling leads to Ca 2+ influx and rapid elevation of cytosolic Ca 2+ (ref. 28) . Because elevated cytosolic Ca 2+ can trigger ERK1 and ERK2 activation by a variety of mechanisms in neurons 29 , we asked whether stimulating TNFα reverse signaling also leads to elevation of cytosolic Ca 2+ in SCG neurons and whether this is a necessary step in ERK1 and ERK2 activation and enhanced neurite growth. Ca 2+ imaging studies showed that treating SCG neurons with TNFR1-Fc, but not with a control Fc fragment, caused a rapid, significant increase in cytosolic Ca 2+ (Fig. 6g) . This elevation did not take place if we treated the neurons with TNFR1-Fc in Ca 2+ -free medium ( Fig. 6g ), suggesting that it was due to Ca 2+ influx. Treating neurons with 1 µM BAPTA-AM, a membrane-permeant acetomethyl ester that chelates cytosolic Ca 2+ when hydrolyzed in the cytoplasm, eliminated the enhanced neurite growth from SCG neurons grown with TNFR1-Fc but had a negligible effect on NGF-promoted neurite growth on its own (Fig. 6h) . Addition of 1 µM BAPTA-AM also prevented activation of ERK1 and ERK2 by TNFR1-Fc without affecting the levels of phospho-ERK1 and phospho-ERK2 on its own (Fig. 6i) . These results suggest that elevation of cytosolic Ca 2+ is a necessary step in activation of ERK1 and ERK2, and enhanced neurite growth brought about by TNFα reverse signaling.
DISCUSSION
Reverse signaling via membrane-integrated members of the TNF superfamily controls multiple aspects of immune function 13 . Although there is a burgeoning literature on the roles of the TNF superfamily in the nervous system in development, physiology and pathology 30, 31 , these roles have been investigated and interpreted in the framework of conventional forward signaling. Here we show that TNF superfamily reverse signaling also occurs in the nervous system. We found that soluble monovalent TNFR1 and divalent TNFR1-Fc chimera, proteins that initiate TNFα reverse signaling in a variety of TNFα-expressing cell lines and cells of the immune system 14-17 , Figure 6 Cytosolic Ca 2+ elevation and ERK1 and ERK2 activation are required for TNFR1-Fc-promoted neurite growth. (a-c) Representative western blots probed for phospho-ERK1 and phospho-ERK2, total ERK1 and ERK2 and β-III tubulin of lysates of P0 SCG neurons grown for 12 h with either 10 ng ml -1 NGF (a), 10 µM Q-VD-OPh without NGF (b) or BAX-deficient neurons without NGF (c) before treatment with 10 ng ml -1 TNFR1-Fc (mean ± s.e.m. of densitometry from four experiments, images were selected from the blots of these four experiments). (d) Representative western blot of lysates of P0 TNFα-deficient neurons grown for 12 h with Q-VD-OPh without NGF before TNFR1-Fc treatment (mean ± s.e.m. of densitometry from three experiments; images were selected from the blots of these three experiments).
(e,f) Branch point number (e) and length (f) of neurons pretreated for 2 h with either 10 µM U0126 or U0124 before TNFR1-Fc addition and incubation for 24 h in medium containing Q-VD-OPh (mean ± s.e.m., >200 neurons per condition from four independent experiments). (g) Change in cytosolic free-Ca 2+ after addition of either Fc fragment or TNFR1-Fc in either Ca 2+ -free medium or medium containing 1.2 mM Ca 2+ (mean ± s.e.m. of three experiments, >20 neurons imaged per condition per experiment). (h) Sholl profiles of P0 SCG neurons cultured for 24 h with either NGF (control) or NGF plus 1 µM BAPTA-AM, TNFR1-Fc or BAPTA-AM plus TNFR1-Fc (mean ± s.e.m., >150 neurons per condition from three independent experiments, **P < 0.01 and ***P < 0.001, comparison with control, Fisher's post hoc test). (i) Representative western blots of lysates of P0 SCG neurons grown for 12 h with Q-VD-OPh without NGF before treatment with either 1 µM BAPTA-AM or BAPTA-AM plus TNFR1-Fc (images selected from three separate experiments of each kind). Full-length western blots are shown in Supplementary Figure 3 . The neurite growth-enhancing effect of TNFR1-Fc was restricted to P0 to P5, when sympathetic axons are growing and ramifying in their targets in vivo under the influence of target-derived NGF 2,3 . TNFR1-Fc not only greatly enhanced the size and complexity of the neurite arbors of postnatal SCG neurons beyond that seen with maximally effective concentrations of NGF but it promoted neurite growth and branching in the absence NGF in cultures in which neuronal apoptosis was prevented by caspase inhibition or deletion of the proapoptotic Bax protein. This indicates that TNFα reverse signaling enhanced neurite growth and branching independently of NGF and could therefore affect axonal growth at various NGF concentrations that developing SCG neurons encounter in vivo.
Although SCG neurons express both TNFα and TNFR1, TNFα is distributed along axons both in vitro and in vivo but TNFR1 expression is restricted to the soma. Expression of TNFR1 in cells in tissues innervated by SCG neurons, together with our demonstration in compartment cultures that TNFR1-Fc enhances axon growth when applied to the axon terminals, but not to the cell soma, suggests that target-derived TNFR1 acts locally on axons to promote growth. TNFR1 expressed in target tissues could act on the membraneintegrated TNFα of the innervating axons either as a soluble, diffusible protein after its release from the cells that synthesize it 32, 33 or as a membrane-integrated protein 34 . Although we do know whether either or both of these alternatives pertain in vivo, the restriction of TNFR1 to the cells that produce it as membrane-integrated protein could potentially have a more precise influence on regulating the local growth, branching and disposition of axons in target tissues. Although SCG neurons express both TNFR1 and TNFα, our observation that the magnitude of NGF-promoted neurite growth from cultured postnatal SCG neurons lacking either TNFR1 or TNFα is similar to that from that from wild-type neurons suggests that any potential autocrine signaling between these membrane proteins does not influence on neurite growth.
The physiological relevance of the axon growth-promoting effect of target-derived TNFR1 on TNFα-expressing sympathetic axons in vivo is amply demonstrated by extensive, blinded quantification of the sympathetic innervation density of several tissues of Tnf and Tnfrsf1a mutant mice and wild-type littermates. This analysis revealed substantial decreases in tyrosine hydroxlyase immunofluorescence in the irides, nasal tissue and submandibular gland of Tnf −/− and Tnfrsf1a −/− mice at P10 compared wild-type littermates. The smaller decreases in tyrosine hydroxlyase immunofluorescence in the nasal tissue of Tnf +/mice and the submandibular gland of Tnfrsf1a +/mice compared to wild-type littermates hint at a gene-dosage effect in heterozygous mice. Quantification of tyrosine hydroxylase protein amounts and numbers of neurons in the SCG of Tnf −/− and Tnfrsf1a −/− mice and corresponding wild-type mice indicated that decreases in sympathetic innervation density were not secondary to decreases in either tyrosine hydroxylase expression or the size of the innervating population of sympathetic neurons. Quantification of sympathetic innervation density using DBH immunofluorescence as an alternative marker of sympathetic fibers, likewise revealed substantial decreases in immunofluorescence in the iris, nasal turbinate tissue and submandibular gland of both Tnf −/− mice and Tnfrsf1a −/− mice compared to wild-type mice. Furthermore, analysis of whole-mount preparations suggests that whereas sympathetic nerves reach their targets in Tnf −/− and Tnfrsf1a −/− mice, many fibers do not to grow into and ramify in these targets. Sympathetic innervation density in adult mice was even lower in Tnf −/− and Tnfrsf1a −/− mice than at P10. Taken together, these studies suggest that TNFR1-activated TNFα reverse signaling substantially contributes to the establishment of sympathetic innervation of several cranial tissues in postnatal mice and the maintenance of sympathetic innervation in throughout life.
In common with TNFα reverse signaling in monocytes 23 , we found that TNFα reverse signaling in postnatal SCG neurons led to a rapid, pronounced and transient activation of ERK1 and ERK2. Like the enhanced neurite growth promoted by TNFR1-Fc, the activation of ERK1/ERK2 by TNFR1-Fc depended on the expression of TNFα and occurred independently of NGF. Several studies have shown that activation of ERK1/ERK2 by NGF in SCG neurons contributes to its ability to promote neurite growth 7, 25, 26 . Our demonstration that pharmacological inhibition of MEK1 and MEK2, the kinases that phosphorylate and activate ERK1 and ERK2, completely prevented neurite growth, enhancing action of TNFR1-Fc, suggests that ERK signaling mediates the effect of TNFα reverse signaling on neurite growth. As in macrophages 28 , activation of TNFα reverse signaling in SCG neurons caused Ca 2+ influx and rapid elevation of cytosolic Ca 2+ . Our demonstration that the intracellular Ca 2+ chelator BAPTA prevented both ERK1 and ERK2 activation and enhanced neurite growth in response to TNFR1-Fc, suggests that elevation of cytosolic Ca 2+ is necessary in mediating the effect of TNFα reverse signaling on neurite growth. The identity of the channels that mediate Ca 2+ influx and how TNFα reverse signaling gates these channels remain intriguing questions.
We previously reported that soluble TNFα decreases the extent of NGF-promoted neurite growth from cultured SCG neurons from newborn mice by a mechanism dependent on IKKβ-activated NF-κB signaling 9 . Our demonstration that SCG neurons cultured from Tnfrsf1a −/− mice lack this inhibitory response suggests that it is mediated by TNFR1. In accordance with the restriction of TNFR1 to the soma of SCG neurons, we only observed the growth-inhibitory effect of soluble TNFα in compartment cultures when TNFα was added to the soma compartment, not the axon compartment. This suggests that target-derived TNFα is unlikely to regulate axon growth in vivo. Moreover, if the growth-inhibitory effect of soluble TNFα observed in vitro were the predominant, physiologically relevant influence of TNFα in vivo, one might predict an increase in sympathetic innervation density in Tnf −/− and Tnfrsf1a −/− mice, not the decrease we observed.
Expression of TNFR1 and TNFR2 by neurons has been implicated in the regulation of neuronal death and survival. There is evidence that TNFα forward signaling via TNFR1 in fetal mouse SCG and trigeminal sensory neurons has a role in accelerating neuronal apoptosis after NGF deprivation 35 . Conversely, TNFα forward signaling via TNFR2 has been implicated in the survival effects of NGF on P5 rat DRG sensory neurons 36 . However, by P10 we observed similar numbers of SCG neurons in Tnf −/− , Tnfrsf1a −/− and wild-type littermates, indicating that by this late stage of development compensatory changes have taken place in these mice for any effects of TNFα on neuronal survival and the timing and magnitude of naturally occurring neuronal death observed earlier in development.
Our discovery of TNF reverse signaling in the nervous system increases our appreciation of the diversity and complexity of signaling between cells in the nervous system and may necessitate a reevaluation of the mechanistic explanation for previous in vivo and in vitro studies of TNFα function in the nervous system. For example, the phenotypic consequences of deleting the Tnf gene may result from npg a r t I C l e S eliminating either forward or reverse signaling. Likewise, the addition of soluble TNFα to cultured cells could either activate forward signaling or interfere with potential endogenous reverse signaling by competing for TNFR1 binding. In addition to providing important new insights into the regulation of the growth of sympathetic axons and the establishment of sympathetic innervation in vivo, our findings highlight the importance of evaluating the relative contributions of forward and reverse signaling in different developmental systems and experimental models.
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Supplementary information is available in the online version of the paper. before being incubated with rabbit, HRP-conjugated antibody (1:300, Promega) in blocking solution at 4 °C overnight. The tissue was then washed for 2 h at room temperature with PBS containing 1% Triton X-100. Tyrosine hydroxylase-positive fibers were visualized by DAB-HRP staining: the tissue was incubated with 1× DAB for 20 min at room temperature and then with 1× DAB containing 0.006% H 2 O 2 for 2-5 min to develop the staining. After washing with PBS, the tissue was and incubated at 4 °C overnight in PBS. BABB (one part benzyl alcohol: two parts benzyl benzoate) was used as a clearing solution. The tissue was placed in 50% methanol for 10 min, washed 3 times with 100% methanol (once for 30 min and twice for 15 min) at room temperature and was incubated in 50% BABB for 5 min before being placed in BABB. To compare the extent of sympathetic nerve branching near the gland hilus, a modified line-intercept method was used. Using ImageJ, a grid of 24 squares (4 × 6 squares) of side length 158 µm per square was aligned in a standard orientation next to the hilus of each gland. The number of fiber bundles intersecting the sides of squares in the grid was scored blind for the glands from each animal. Fiber density was estimated using the formula πDI/2, where D is the interline interval (158) and I the mean number of intersections along one side of each square in the grid. The data are expressed as a percentage of the mean data for wild-type mice.
Quantification of neuron numbers in Scg.
Estimates of the numbers of neurons in the SCG of P10 Tnfrsf1a +/+ , Tnfrsf1a −/− , Tnf +/+ and Tnf −/− pups were carried out by stereological analysis of ganglia serially sectioned at 8 µm and immunolabeled for β-III tubulin, as described previously 35 . The analysis was done in a blinded fashion to avoid any observer bias.
Immunoblotting. Immunoblotting was carried out using the BioRad TransBlot (BioRad) as previously described 40 . The blots were probed with antibodies to phospho-ERK1/ERK2 (1:1,000, Cell Signaling, 9101), total ERK1/ERK2 (1:1,000, Cell Signaling, 9102) or β-III tubulin (1:10,000, R&D systems, MAB1195). Binding of the primary antibodies was visualized with an HRP-conjugated secondary antibody (1:2,000; Promega, either W4021 or W4011) and ECL-plus reagent (Amersham). Densitometry was carried out using Gel-Pro Analyzer 32 program (Media Cybernetics). The levels of phospho-ERK1 and phospho-ERK2 were normalized to the levels of total ERK1 and ERK2. calcium imaging. SCG neurons were cultured at high density (50,000 cells per 35-mm dish) in medium containing 10 ng/ml NGF plus an inhibitor of TNFα processing (TAPI-0, 300 nM, Enzo Life Sciences) to inhibit cleavage of membrane integrated TNFα. Twelve hours after plating, the medium was changed to Ringer's solution (125 mM NaCl, 4 mM KCl, 1.2 mM CaCl 2 , 0.5 mM MgCl 2 , 10 mM glucose and 10 mM HEPES, pH 7.4) or containing 0.1% BSA and Fura-2 AM (1 mg/ml, Invitrogen). After another 30 min at room temperature, the cells were washed twice for 10 min with Ringer's solution or Ca 2+ -free Ringer's solution (Ca 2+ -free Ringer's solution (125 mM NaCl, 4 mM KCl, 0.5 mM MgCl 2 , 10 mM glucose and 10 mM HEPES, pH 7.4)) and were treated with either 5 µg/ml TNFR1-Fc in Ringer's solution or Ca 2+ -free Ringer's solution or 5 µg/ml Fc fragment in Ringer's solution. Time-lapse imaging of the 340/380 nm ratio was carried out at intervals using a Zeiss Axiovert 200 fluorescence microscope. At least 20 neurons were imaged per condition in each experiment, and the mean percentage change in the 340/380 nm ratio (minus background) was calculated.
Statistical analysis. Data are expressed as mean and standard errors. No statistical methods were used to predetermine sample sizes but our sample sizes are similar to those generally used in the field. Following normality test and homogeneity variance (F-test), group comparison were made using a t-test or one-way ANOVA as appropriate followed by Fisher's post hoc test for normally distributed data. A nonparametric test, the Kruskal-Wallis test, was performed for data that were not normally distributed. Differences were considered significant for P < 0.05. The experiments were not randomized. Data from all experiments are included; none were excluded.
